Service is in preparation Official β release coming soon. Some features are still being adjusted.

Investical Earnings & investing calendar Earnings & investing calendar
/
177ATSE Growth

Kohjin Bio Co.,Ltd.

コージンバイオ Yahoo Finance

Recent & upcoming events

Aug 14
Earnings 2:00
Q1 earnings announcement (scheduled)
Add to Google Calendar
Jun 25
Shareholder meeting Time TBD
Shareholders' meeting
Add to Google Calendar
May 15
Earnings 2:00
FY earnings announcement (scheduled)
Add to Google Calendar
Sep 27
Est.
Dividend Time TBD
Last day with rights (interim)
Add to Google Calendar
Sep 28
Est.
Ex-dividend Time TBD
Ex-rights date (interim)
Add to Google Calendar
Nov 13
Est.
Earnings 1:00 approx.
Q2 earnings
Add to Google Calendar
2027
Feb 12
Est.
Earnings 1:00 approx.
Q3 earnings
Add to Google Calendar
Mar 28
Est.
Dividend Time TBD
Last day with rights (year-end)
Add to Google Calendar
Mar 29
Est.
Ex-dividend Time TBD
Ex-rights date (year-end)
Add to Google Calendar
May 14
Est.
Earnings 2:00 approx.
Full-year earnings
Add to Google Calendar
Aug 13
Est.
Earnings 2:00 approx.
Q1 earnings
Add to Google Calendar

KPI highlights

FY26
Revenue ¥4.94B YoY -5.1%
Operating income ¥342M margin 6.9%
Net income ¥251M YoY -68.4%
EPS ¥49 YoY -68.8%
P/E —
ROE 4.3% Equity ratio 67% Typical equity ratios vary a lot by industry. Banks, brokerages, and other financial companies tend to run lower ratios because leverage (using other people's capital) is core to their business model — a low ratio there isn't a sign of financial weakness.

Company guidance

FY2027/03 Company-issued full-year guidance (from earnings report) / %=vs prior FY
Revenue ¥4.72B -4.4%
Operating income ¥137M -59.9%
Net income ¥110M -56.2%
EPS ¥22 -55.9%

Quarterly fundamentals

Income & cash flow
Quarter FY24 Q1FY24 Q2FY25 Q2
Revenue ¥1.23B——
Operating income ¥226M——
Net income ¥178M——
Operating CF ———

Ownership over time

Share of total shares outstanding (disclosed major holdings + undisclosed)（2024–2026）

事業法人 19.6%海外機関 12.1%個人 47%未開示 21.3%202420252026
事業法人国内機関海外機関個人未開示・浮動株

「国内機関」は信託銀行の名義口座（年金・パッシブ・一部海外資本を含む）を集計し、実質保有者へは分解していません。分類は開示名称からの推定です。

Top shareholders — rank & share

中村　孝人 43.2%中村　孝人TAKAコーポレーション株式会社 8.2%TAKAコーポレーション株式会社GOLDMAN SACHS INTE 7.6%GOLDMAN SACHS INTERNATIONAL(常任代理人 ゴールドマン・サックス証券株式会社)オリエンタル酵母工業株式会社 5.3%オリエンタル酵母工業株式会社BNY GCM CLIENT ACC 4.5%BNY GCM CLIENT ACCOUNT JPRD AC ISG （FE－AC）（常任代理人　株式会社三菱UFJ銀行）富士フイルム和光純薬株式会社 2.7%富士フイルム和光純薬株式会社コージンバイオ従業員持株会 2.3%コージンバイオ従業員持株会コスモ・バイオ株式会社 2%コスモ・バイオ株式会社202420252026

Top shareholders — actual figures (as of 2026)

Holder Shares held Ratio Source
中村 孝人 2,209,500 43.2% Yuho (EDINET)
TAKAコーポレーション株式会社 416,500 8.2% Yuho (EDINET)
GOLDMAN SACHS INTERNATIONAL 389,478 7.6% Yuho (EDINET)
オリエンタル酵母工業株式会社 270,000 5.3% Yuho (EDINET)
BNY GCM CLIENT ACCOUNT JPRD AC ISG （FE－AC） 228,452 4.5% Yuho (EDINET)
富士フイルム和光純薬株式会社 140,000 2.7% Yuho (EDINET)
コージンバイオ従業員持株会 118,579 2.3% Yuho (EDINET)
コスモ・バイオ株式会社 100,000 2.0% Yuho (EDINET)
渡辺 恒美 78,900 1.5% Yuho (EDINET)
家田化学薬品株式会社 72,000 1.4% Yuho (EDINET)

Source：EDINET（大株主の状況）　Classification inferred from disclosed names

F-Score (Piotroski)

5/9

Checks financial health against 9 criteria and shows how many are met as a fraction (more ✓ marks is healthier). Items with no data are shown as “—” — they're simply excluded from judgment, not counted against the score.

✓ Positive ROA ROA 2.8%
✓ Positive operating cash flow ¥699M
✗ ROA improved YoY 8.8% → 2.8%
✓ Operating CF exceeds net income (accrual quality) OCF ¥699M / net income ¥251M
✓ Equity ratio improved* Substitute for the original “decrease in long-term debt” 63.8% → 66.8%
✗ Current ratio improved 2.04× → 1.80×
✓ No dilution (shares outstanding did not increase) 5,111,600 → 5,111,600
✗ Gross margin improved 45.4% → 37.6%
✗ Asset turnover improved 0.57× → 0.55×

This score is reference information based on our own financial metrics. It is NOT a credit rating issued by a credit rating agency under Article 66-27 of the Financial Instruments and Exchange Act, and is NOT investment advice or a recommendation. Make investment decisions at your own responsibility.

Fact checklist

FY26
Equity ratio 66.8%
Current ratio 1.8×
Years of positive operating CF 5 of last 5 yrs
Payout ratio 82%
Latest fiscal year result Profit (net income ¥251M)

Performance history

Last 10 years
0億円13億円26億円39億円52億円 FY22FY23FY24FY25FY26

Income & assets

Unit: ¥100M
Item FY22FY23FY24FY25FY26
Revenue 39.547.447.752.149.4
Operating income 9.7012.75.979.913.42
Ordinary income ——6.3610.73.41
Net income 5.888.303.857.952.51
Total assets 56.061.365.990.789.0
Equity 22.230.233.457.859.5

A “—” means data wasn't available for that period — it's not a display error or an unusual value.

Indicators & cash flow

Unit: ¥100M
Item FY22FY23FY24FY25FY26
EPS ¥117¥199¥92¥158¥49
ROE 26.5%27.5%12.1%17.4%4.3%
Operating CF 7.199.778.249.166.99
Investing CF 0.84-5.75-5.77-10.9-8.68
Financing CF -3.37-4.51-0.0113.8-3.21
FCF 5.59-1.002.46-1.75-1.69

Source: EDINET (Annual Securities Report) (fetched 2026-08-29) *Some metrics supplemented from additional sources

Sector positioning

Relative standing within the sector
Is this information incorrect?

Data provided by Twelve Data